Cryoablation Combined With Lenvatinib Plus QL1706 (Iparomlimab/Tuvonralimab) in Patients With Advanced Intrahepatic Cholangiocarcinoma

NCT07070700 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

56

Enrollment

OTHER

Sponsor class

Conditions

Intrahepatic Cholangiocarcinoma (Icc)

Interventions

DRUG: QL1706 (bispecific antibody targeting PD-1 and CLTA-4)
DRUG: Lenvatinib
PROCEDURE: cryoablation

Sponsor

Fudan University